[Catheter-based intervention therapies for ischemic heart disease]

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Preventive Cardiology

Context:

• Drug-eluting stents (DES) have significantly reduced restenosis rates following percutaneous coronary intervention (PCI).
• Long-term prognosis comparison between PCI and coronary artery bypass grafting (CABG) remains a critical clinical question.
• The focus in coronary revascularization is shifting from restenosis management to long-term patient outcomes.

Purpose:

• To evaluate the long-term prognostic differences between PCI and CABG.
• To explore the potential of Optimal Medical Therapy (OMT) to enhance PCI outcomes.
• To establish minimally invasive treatment as a viable alternative to traditional surgery.

Summary:

• While DES have overcome restenosis, PCI still shows inferior long-term prognosis compared to CABG.
• Implementing OMT, a combination of lifestyle changes and tailored drug therapy, is crucial for improving PCI outcomes.
• Augmenting PCI with OMT may lead to long-term results equivalent to CABG, heralding an era of truly minimally invasive coronary revascularization.

Impact:

• Highlights the paramount importance of secondary prevention strategies in managing coronary artery disease post-PCI.
• Suggests that OMT can bridge the gap in long-term efficacy between PCI and CABG.
• Paves the way for advanced, minimally invasive approaches in cardiac care, improving patient prognosis and quality of life.